← Back to headlines
Alvotech Initiates $125 Million Fundraising for Biosimilar Growth
Alvotech has launched a $125 million fundraising initiative through both public and private offerings, aimed at fueling the company's growth in the biosimilar market.
15 Jun, 20:18 — 15 Jun, 20:18
Sources
Showing 1 of 1 sources
